Guideline on Virus Safety Evaluation of Biotechnological Investigational Medicinal Products

七月 10, 2006

London, 07 Jul 2006

Full text

[...]

EXECUTIVE SUMMARY

The purpose of this document is to provide scientific guidance relating to the viral safety of biotechnological medicinal products used in clinical trials. Guidance is provided with respect to:

  • the criteria for and the extent of viral safety evaluation studies, especially validation studies, that are required prior to and during clinical development.

  • the extent to which manufacturers are able to refer to in-house experience concerning virus safety evaluation.

  • the risk assessment which should form part of the safety evaluation.

    [...]

    Full text

    European Agency for the Evaluation of Medicinal Products - EMEA

    • 请先注册再继续

    为何要注册？

    • 注册是免费的，而且十分便捷
    • 注册成功后，您每月可免费阅读3篇文章
    • 订阅我们的邮件
    注册
    Please 登录 or 注册 to read this article.